198 related articles for article (PubMed ID: 22704563)
1. Metabolic syndrome (MetS) predicts cardio and cerebrovascular events in a twenty years follow-up. A prospective study.
Novo S; Peritore A; Guarneri FP; Corrado E; Macaione F; Evola S; Novo G
Atherosclerosis; 2012 Aug; 223(2):468-72. PubMed ID: 22704563
[TBL] [Abstract][Full Text] [Related]
2. Prediction model with metabolic syndrome to predict recurrent vascular events in patients with clinically manifest vascular diseases.
Wassink AM; van der Graaf Y; Janssen KJ; Cook NR; Visseren FL;
Eur J Prev Cardiol; 2012 Dec; 19(6):1486-95. PubMed ID: 22008749
[TBL] [Abstract][Full Text] [Related]
3. Preclinical atherosclerosis and metabolic syndrome increase cardio- and cerebrovascular events rate: a 20-year follow up.
Novo S; Peritore A; Trovato RL; Guarneri FP; Di Lisi D; Muratori I; Novo G
Cardiovasc Diabetol; 2013 Oct; 12():155. PubMed ID: 24152423
[TBL] [Abstract][Full Text] [Related]
4. Subclinical atherosclerosis is associated with Epicardial Fat Thickness and hepatic steatosis in the general population.
Baragetti A; Pisano G; Bertelli C; Garlaschelli K; Grigore L; Fracanzani AL; Fargion S; Norata GD; Catapano AL
Nutr Metab Cardiovasc Dis; 2016 Feb; 26(2):141-53. PubMed ID: 26777475
[TBL] [Abstract][Full Text] [Related]
5. Impact of preclinical carotid atherosclerosis on global cardiovascular risk stratification and events in a 10-year follow-up: comparison between the algorithms of the Framingham Heart Study, the European SCORE and the Italian 'Progetto Cuore'.
Novo S; Carità P; Lo Voi A; Muratori I; Tantillo R; Corrado E; Kalodiki E; Novo G
J Cardiovasc Med (Hagerstown); 2019 Feb; 20(2):91-96. PubMed ID: 30557211
[TBL] [Abstract][Full Text] [Related]
6. Metabolic syndrome, diabetes mellitus, or both and cardiovascular risk in outpatients with or at risk for atherothrombosis.
Udell JA; Steg PG; Scirica BM; Eagle KA; Ohman EM; Goto S; Alsheikh-Ali AA; Porath A; Corbalan R; Umez-Eronini AA; Hoffman EB; Wilson PW; Bhatt DL;
Eur J Prev Cardiol; 2014 Dec; 21(12):1531-40. PubMed ID: 23918840
[TBL] [Abstract][Full Text] [Related]
7. Liraglutide improves metabolic parameters and carotid intima-media thickness in diabetic patients with the metabolic syndrome: an 18-month prospective study.
Rizzo M; Rizvi AA; Patti AM; Nikolic D; Giglio RV; Castellino G; Li Volti G; Caprio M; Montalto G; Provenzano V; Genovese S; Ceriello A
Cardiovasc Diabetol; 2016 Dec; 15(1):162. PubMed ID: 27912784
[TBL] [Abstract][Full Text] [Related]
8. Association of metabolic syndrome with carotid atherosclerosis in the young North Indian population.
Bal SS; Khurana D; Sharma A; Lal V; Bhansali A; Prabhakar S
Diabetes Metab Syndr; 2011; 5(3):153-7. PubMed ID: 22813569
[TBL] [Abstract][Full Text] [Related]
9. Metabolic syndrome: A predictor of adverse outcomes after carotid revascularization.
Protack CD; Bakken AM; Xu J; Saad WA; Lumsden AB; Davies MG
J Vasc Surg; 2009 May; 49(5):1172-80.e1; discussion 1180. PubMed ID: 19394545
[TBL] [Abstract][Full Text] [Related]
10. Non-alcoholic fatty liver disease, metabolic syndrome and subclinical cardiovascular changes in the general population.
Kim NH; Park J; Kim SH; Kim YH; Kim DH; Cho GY; Baik I; Lim HE; Kim EJ; Na JO; Lee JB; Lee SK; Shin C
Heart; 2014 Jun; 100(12):938-43. PubMed ID: 24721975
[TBL] [Abstract][Full Text] [Related]
11. Nonalcoholic fatty liver disease is an independent risk factor for atherosclerosis in young adult men.
Ozturk K; Uygun A; Guler AK; Demirci H; Ozdemir C; Cakir M; Sakin YS; Turker T; Sari S; Demirbas S; Karslıoğlu Y; Saglam M
Atherosclerosis; 2015 Jun; 240(2):380-6. PubMed ID: 25875390
[TBL] [Abstract][Full Text] [Related]
12. Progression of carotid vascular damage and cardiovascular events in non-alcoholic fatty liver disease patients compared to the general population during 10 years of follow-up.
Fracanzani AL; Tiraboschi S; Pisano G; Consonni D; Baragetti A; Bertelli C; Norata D; Valenti L; Grigore L; Porzio M; Catapano A; Fargion S
Atherosclerosis; 2016 Mar; 246():208-13. PubMed ID: 26803429
[TBL] [Abstract][Full Text] [Related]
13. The metabolic syndrome, atherosclerosis and cognitive functioning in a non-demented population: the Hoorn Study.
Reijmer YD; van den Berg E; Dekker JM; Nijpels G; Stehouwer CD; Kappelle LJ; Biessels GJ
Atherosclerosis; 2011 Dec; 219(2):839-45. PubMed ID: 21959256
[TBL] [Abstract][Full Text] [Related]
14. Asymptomatic carotid lesions add to cardiovascular risk prediction.
Novo S; Visconti CL; Amoroso GR; Corrado E; Fazio G; Muratori I; Tantillo R; Lunetta M; D'Angelo L; Novo G
Eur J Cardiovasc Prev Rehabil; 2010 Oct; 17(5):514-8. PubMed ID: 20351551
[TBL] [Abstract][Full Text] [Related]
15. Association between interleukin-6 levels and first-ever cerebrovascular events in patients with vascular risk factors.
Miwa K; Tanaka M; Okazaki S; Furukado S; Sakaguchi M; Mochizuki H; Kitagawa K
Arterioscler Thromb Vasc Biol; 2013 Feb; 33(2):400-5. PubMed ID: 23175672
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of metabolic syndrome: a comparative analysis in an unselected sample of mediterranean subjects.
Corrado E; Rizzo M; Caccamo G; Coppola G; Muratori I; Tantillo R; Dell'oglio S; Nugara C; Macaione F; Novo G; Alcamo R; Mignano A; Ferrara F; Novo S
Int Angiol; 2012 Dec; 31(6):572-8. PubMed ID: 23222936
[TBL] [Abstract][Full Text] [Related]
17. A longitudinal analysis on associations of adiponectin levels with metabolic syndrome and carotid artery intima-media thickness. The Cardiovascular Risk in Young Finns Study.
Juonala M; Saarikoski LA; Viikari JS; Oikonen M; Lehtimäki T; Lyytikäinen LP; Huupponen R; Magnussen CG; Koskinen J; Laitinen T; Taittonen L; Kähönen M; Kivimäki M; Raitakari OT
Atherosclerosis; 2011 Jul; 217(1):234-9. PubMed ID: 21481397
[TBL] [Abstract][Full Text] [Related]
18. Increased subclinical atherosclerosis in young adults with metabolic syndrome: the Bogalusa Heart Study.
Tzou WS; Douglas PS; Srinivasan SR; Bond MG; Tang R; Chen W; Berenson GS; Stein JH
J Am Coll Cardiol; 2005 Aug; 46(3):457-63. PubMed ID: 16053958
[TBL] [Abstract][Full Text] [Related]
19. Progression of subclinical atherosclerosis in subjects with rheumatoid arthritis and the metabolic syndrome.
Burggraaf B; van Breukelen-van der Stoep DF; de Vries MA; Klop B; van Zeben J; van de Geijn GM; van der Meulen N; Birnie E; Prinzen L; Castro Cabezas M
Atherosclerosis; 2018 Apr; 271():84-91. PubMed ID: 29482038
[TBL] [Abstract][Full Text] [Related]
20. Impact of metabolic syndrome on future cardiovascular events in patients with first acute myocardial infarction.
Selcuk H; Temizhan A; Selcuk MT; Sen T; Maden O; Tekeli S; Sasmaz A
Coron Artery Dis; 2009 Sep; 20(6):370-5. PubMed ID: 19609207
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
